Clinical Trial Update: A Study of Once-Monthly Subcutaneous Mircera for the Treatment of Chronic Renal Anemia in Pre-Dialysis Patients Not Currently Treated With ESA. [Phase 3]

View source ↗

Summary

Phase 3 study evaluating once-monthly subcutaneous Mircera for chronic renal anemia in pre-dialysis patients not currently treated with erythropoiesis-stimulati…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anemia
• Chronic Kidney Disease

Drugs mentioned

• MIRCERA (METHOXY POLYETHYLENE GLYCOL-EPOETIN BETA)

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Anemia | Phase 3 | Status: TERMINATED